1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validation
2.7. Assumptions
and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Pharmacokinetics
Services Market Outlook
5.1. Market Size & Forecast
5.1.1.
By Value
5.2. Market Share & Forecast
5.2.1.
By Drug
Type (Small Molecules, Large Molecules)
5.2.2.
By Application (Small and Medium
Enterprise, Large Enterprise)
5.2.3.
By End-use (Biotechnology &
Pharmaceutical Companies, Academic & Government Research Institutes,
others)
5.2.4.
By Region
5.2.5.
By Company (2023)
5.3. Market Map
6.
Asia Pacific Pharmacokinetics
Services Market Outlook
6.1. Market Size & Forecast
6.1.1.
By Value
6.2. Market Share & Forecast
6.2.1.
By Drug Type
6.2.2.
By Application
6.2.3.
By End-use
6.2.4.
By Country
6.3. Asia Pacific: Country Analysis
6.3.1.
China Pharmacokinetics
Services Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Drug Type
6.3.1.2.2.
By Application
6.3.1.2.3.
By End-use
6.3.2.
India Pharmacokinetics
Services Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Drug Type
6.3.2.2.2.
By Application
6.3.2.2.3.
By End-use
6.3.3.
Australia Pharmacokinetics
Services Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Drug Type
6.3.3.2.2.
By Application
6.3.3.2.3.
By End-use
6.3.4.
Japan Pharmacokinetics
Services Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Drug Type
6.3.4.2.2.
By Application
6.3.4.2.3.
By End-use
6.3.5.
South Korea Pharmacokinetics
Services Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Drug Type
6.3.5.2.2.
By Application
6.3.5.2.3.
By End-use
7.
Europe Pharmacokinetics
Services Market Outlook
7.1. Market Size & Forecast
7.1.1.
By Value
7.2. Market Share & Forecast
7.2.1.
By Drug Type
7.2.2.
By Application
7.2.3.
By End-use
7.2.4.
By Country
7.3. Europe: Country Analysis
7.3.1.
France Pharmacokinetics
Services Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug Type
7.3.1.2.2.
By Application
7.3.1.2.3.
By End-use
7.3.2.
Germany Pharmacokinetics
Services Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug Type
7.3.2.2.2.
By Application
7.3.2.2.3.
By End-use
7.3.3.
Spain Pharmacokinetics
Services Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug Type
7.3.3.2.2.
By Application
7.3.3.2.3.
By End-use
7.3.4.
Italy Pharmacokinetics
Services Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Drug Type
7.3.4.2.2.
By Application
7.3.4.2.3.
By End-use
7.3.5.
United Kingdom Pharmacokinetics
Services Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Drug Type
7.3.5.2.2.
By Application
7.3.5.2.3.
By End-use
8.
North America Pharmacokinetics
Services Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share & Forecast
8.2.1.
By Drug Type
8.2.2.
By Application
8.2.3.
By End-use
8.2.4.
By Country
8.3. North America: Country Analysis
8.3.1.
United States Pharmacokinetics
Services Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug Type
8.3.1.2.2.
By Application
8.3.1.2.3.
By End-use
8.3.2.
Mexico
Pharmacokinetics Services Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug Type
8.3.2.2.2.
By Application
8.3.2.2.3.
By End-use
8.3.3.
Canada Pharmacokinetics
Services Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug Type
8.3.3.2.2.
By Application
8.3.3.2.3.
By End-use
9.
South America Pharmacokinetics
Services Market Outlook
9.1. Market Size & Forecast
9.1.1.
By Value
9.2. Market Share & Forecast
9.2.1.
By Drug Type
9.2.2.
By Application
9.2.3.
By End-use
9.2.4.
By Country
9.3. South America: Country Analysis
9.3.1.
Brazil Pharmacokinetics
Services Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug Type
9.3.1.2.2.
By Application
9.3.1.2.3.
By End-use
9.3.2.
Argentina Pharmacokinetics
Services Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Drug Type
9.3.2.2.2.
By Application
9.3.2.2.3.
By End-use
9.3.3.
Colombia
Pharmacokinetics Services Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Drug Type
9.3.3.2.2.
By Application
9.3.3.2.3.
By End-use
10.
Middle East and Africa
Pharmacokinetics Services Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1.
By Drug Type
10.2.2.
By Application
10.2.3.
By End-use
10.2.4. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Pharmacokinetics Services Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Drug Type
10.3.1.2.2.
By Application
10.3.1.2.3.
By End-use
10.3.2. Saudi Arabia Pharmacokinetics Services Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Drug Type
10.3.2.2.2.
By Application
10.3.2.2.3.
By End-use
10.3.3. UAE Pharmacokinetics Services Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Drug Type
10.3.3.2.2.
By Application
10.3.3.2.3.
By End-use
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Developments
12.2.
Product Launches
12.3.
Mergers &
Acquisitions
13.
Porter’s Five Forces
Analysis
13.1.
Competition in the
Industry
13.2.
Potential of New
Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute
Product
14. Competitive Landscape
14.1.
Evotec AG
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (In case of listed companies)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Certara, L.P.
14.3. Pacific BioLabs
14.4. GVK Biosciences Private Limited
14.5.
Shanghai Medicilon Inc.
14.6.
Pharmaceutical Product Development, LLC
14.7.
Charles River Laboratories International, Inc.
14.8.
PAREXEL International Corporation
14.9.
Eurofins Scientific SE
14.10.Frontage Labs
15. Strategic
Recommendations
16. About Us & Disclaimer